NEXT GEN - PHILIPS OPTIMUS

Part of paid clinical trials in Louisville, Colorado.

Sponsor
Philips Clinical & Medical Affairs Global
Study ID
NCT07521735
Status
Recruiting
Apply to this trial

Conditions

  • Pulse Oximetry

Eligibility Criteria

Sex
ALL
Age
18 Years - 50 Years
Healthy Volunteers
Accepted

Interventions

  • Philips MR400 Pro MRI Patient Monitor — DEVICE
    Philips IntelliVue Patient Monitor X3 Philips Adult SpO2 Sensor (M1191BL) Philips Wireless Patient Module SpO2 (Gen-4) SpO2 Sensor, MRI (Gen-4) Adult SpO2 Glove Adult SpO2 Grips

Study Details

The purpose of this clinical study is to validate the SpO2 accuracy performance of the sponsor's SpO2 sensors over the range of 70-100% SaO2 during non-motion conditions assessed by CO-Oximetry.

Key Dates

Start date
Mar 9, 2026
Status verified
Apr 2026
Primary completion
Apr 3, 2026
Completion
Apr 3, 2026

Study Design

Enrollment
36 participants (estimated)

Arms

  • Arm: Study Population - 18 to 50 Years
    The study population will include a minimum of 36 participants up to a maximum of 72, healthy male and female volunteers of any race, ranging in pigmentation from light to dark.

Primary Outcome Measure

SpO2 accuracy [ Time Frame: March-April 2026 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Element Materials TechnologyLouisvilleColorado80027
Monica Rabanal, NP
[email protected]

Find similar trials in Louisville, CO

By research site
Element Materials Technology· Louisville, CO